JavaScript is currently not supported/disabled by this browser. Please enable JavaScript for full functionality.
Loding Loading ....

AAV Capsids

Hero Background

Integrated AAV Offerings: From Cutting-Edge Products to Advanced Custom Services

Overcoming AAV Technology Challenges with Expertly Tailored Vector Design and Production 

AAV Capsids Screening & Engineering

Adeno-associated virus (AAV) capsids are the outer protein shells that protect and deliver the viral genome into target cells. While AAV capsids have become essential tools for gene therapy and research, current challenges such as immune response, tissue specificity, and limited cargo capacity can affect their efficacy. To overcome these limitations, researchers need to screen large capsid libraries to identify the most suitable capsid for their specific research needs. In addition, engineering new capsids has also become a promising strategy to improve the efficacy and safety of AAV vector systems in clinical applications. Engineered capsids are designed to reduce the required vector dose, lower the risk of immune responses, decrease manufacturing costs, and provide solutions for patients with preexisting immunity to natural AAV serotypes.

In partnership with AAVnerGene, we present the ATHENA AAV Capsid Platform, a comprehensive suite of technologies designed to rapidly evaluate, evolve, and develop novel AAV serotypes or variants for specific therapeutic applications. The ATHENA platform is comprised of two distinct sub-platforms: ATHENA-I, and ATHENA-II, each designed to tackle different aspects of AAV capsid discovery and optimization.

Learn About ATHENA platforms

ATHENA I (Known Capsid library)

ATHENA-I Platform: AAV Capsid Evaluation and Selection

The ATHENA-I platform is designed for the systematic evaluation of different AAV serotypes or variants using Barcode-Seq technology.

AAV Capsid Barcode Kits: Created using the ATHENA-I platform, these kits allow researchers to assess the efficiency of various AAV capsid variants. Each capsid variant is assigned three different DNA barcodes, and through next-generation sequencing (NGS) of the DNA or RNA levels, researchers can determine the most efficient AAV capsid for their specific applications.

Available Kits: AAVnerGene provides both common and tissue-specific AAV Capsid Barcode Kits based on the ATHENA-I platform. The common kits include 15 widely used AAV serotypes, while tissue-specific kits contain an additional 9 selected tissue-targeting capsids. Custom library services are also available, allowing users to integrate their own reporter systems and specific capsids.
 

Learn More
ATHENA II (Random Peptide library)

ATHENA-II Platform: AAV Capsid Evolution

The ATHENA-II platform focuses on evolving novel AAV capsids with tissue-specific tropism from high-complexity random peptide insertion libraries.

AAV Capsid Libraries: These libraries are built on the ATHENA-II platform and involve CAP genes with random peptides driven by a CAG/P40 hybrid promoter. The P40 promoter drives CAP expression during AAV production, while the CAG promoter drives CAP expression in target cells or tissues. The random peptides serve as barcodes for enrichment analysis.

Available Libraries: AAVnerGene offers AAV Capsid Libraries with different serotypes, variable regions for peptide insertion, and random peptide lengths. Each library has a complexity of over one billion. Custom library construction, production, and evolution services are also provided.

Learn More

AAV Services

AAV Vector Design & Cloning

Expert consultation, design, gene synthesis, and cloning of custom AAV vectors tailored to your research needs.

Learn more

AAV Packaging Service

Reliable, affordable, and fully customizable AAV packaging service with diverse serotype options and high titer.

Learn more

AAV QC & Characterization

Comprehensive quality control assays including qPCR, SDS-PAGE, mass photometry, and next-generation sequencing.

Learn more

Other Viruses at Biohippo

Rabies Virus (RV)

Neural Circuit Tracing

Biohippo offers a variety of viral vectors, including RV, HSV, PRV, and VSV, to replace conventional tracers with the highly efficient, more specific, and less invasive viral method.

Learn More
Rabies Virus (RV)

Lentivirus

Biohippo offers TF reporter lentivirus, immunotherapy lentivirus, validated shRNA, cDNA, and miRNA lentiviruses to meet diverse research needs. We also offer customized service at affodable price.

Learn More